Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Oculex Phase II macular edema data

Oculex (Sunnyvale, Calif.) said that 700 ug of its Posurdex implant met

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE